Much of our current understanding of immune mechanisms underlying multiple sclerosis (MS) comes from studies of experimental autoimmune encephalomyelitis (EAE) in mice. In 1 form of the model, immunization with the 35-55 peptide of myelin oligodendrocyte glycoprotein (MOG) induces chronic progressive disease with many manifestations of MS. Recently, we found that following MOG 35-55 immunization, mice deficient in decay accelerating factor (DAF), an intrinsic cell surface regulator previously thought to exclusively control complement C3/C5 convertases, develop dramatically more severe EAE than wild type (WT) controls. Clinical scores are markedly higher, lymphocyte infiltration and demyelination in dorsal columns are profoundly increased, and in cell-mediated immune assays, CD4+ T cells show 8-fold stronger MOG 35-55 recall responses as assessed both by proliferation and IFN-gamma ELISPOT assays. Prompted by this result, we studied DAF's effect both in vitro and in vivo on the induction of T cell immune reactivity, and unexpectedly found that it possesses potent inhibitory activity via effects both on antigen presenting cells (APCs) and responder CD4+ and CD8+ cells. In recent work we have found that 1) autoreactivity in MOG 35-55 induced EAE extends to proteolipid protein (PLP) and 2) mice doubly deficient in DAF and CD59, a related intrinsic complement inhibitor that works together with DAF, develop even more severe disease than DAF deficient mice. Some studies have shown that, in addition to T cell reactivity, complement participates in EAE pathogenesis, and a recent study has reported that CD59 protects against disease induced with whole MOG protein. Whether DAF's and CD59's protective effects in EAE are mediated via T cell inhibition, complement inhibition, or both is not established. Nevertheless, in view of our new findings of DAF's function as a T cell activation inhibitor as well as a complement inhibitor, and potentially similar effects of CD59, engineered recombinant DAF or CD59 could, in principle, constitute new therapeutic approaches for treating MS. In the proposed research we will 1) determine the extent to which deficiency of CD59 affects anti-myelin T cell autoreactivity as well as complement attack in both MOG 35-55-and PLP-induced EAE, 2) determine the cellular site(s) at which DAF (and CD59 if found) are exerting immune inhibitory activity, and, based on 1) and 2) develop appropriately targeted DAF (and/or CD59) therapeutic agents and test their abilities to ameliorate disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS052471-01
Application #
6957581
Study Section
Special Emphasis Panel (ZRG1-IMM-E (02))
Program Officer
Utz, Ursula
Project Start
2005-09-15
Project End
2010-08-31
Budget Start
2005-09-15
Budget End
2006-08-31
Support Year
1
Fiscal Year
2005
Total Cost
$250,097
Indirect Cost
Name
Case Western Reserve University
Department
Pathology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Drucker, Kristen L; Gianinni, Caterina; Decker, Paul A et al. (2015) Prognostic significance of multiple kallikreins in high-grade astrocytoma. BMC Cancer 15:565
Drucker, Kristen L; Paulsen, Alex R; Giannini, Caterina et al. (2013) Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma. Neuro Oncol 15:305-18
Li, Yan; Smith, Dawn; Li, Qing et al. (2012) Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 53:5520-6
Tu, Zhidan; Li, Yan; Smith, Dawn et al. (2012) Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 53:959-66
Li, Yan; Lin, Feng (2012) Mesenchymal stem cells are injured by complement after their contact with serum. Blood 120:3436-43
Tu, Zhidan; Li, Qing; Chou, Hong-Shiue et al. (2011) Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology 216:528-34
Tu, Zhidan; Li, Yan; Smith, Dawn S et al. (2011) Retinal pericytes inhibit activated T cell proliferation. Invest Ophthalmol Vis Sci 52:9005-10
Tu, Zhidan; Portillo, Jose-Andres C; Howell, Scott et al. (2011) Photoreceptor cells constitutively express functional TLR4. J Neuroimmunol 230:183-7
Tu, Zhidan; Li, Qing; Bu, Hong et al. (2010) Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev 19:1803-9
Tu, Zhidan; Cohen, Mark; Bu, Hong et al. (2010) Tissue distribution and functional analysis of Sushi domain-containing protein 4. Am J Pathol 176:2378-84

Showing the most recent 10 out of 19 publications